Gland Pharma IPO will be India's largest pharma IPO in the history. The company is coming up with 1250 crore fresh issue and 5229 crores of offer for sale. The company was incorporated in 1978 based in Hyderabad. The company is a manufacturer, marketer, and developer of complex injectables across its seven manufacturing facilities.
Gland Pharma is a holistic objective of dispensing health through a portfolio of injectable products across various therapeutic segments and delivery systems, has helped gland pharma expand to seven manufacturing facilities in India, with a capacity of approximately 750 million units. These include four facilities with 22 production lines for finished formulations and three Active Pharmaceutical Ingredient (API) facilities. Gland Pharma products are produced at world-class manufacturing facilities and conform to global compliance, regulatory and quality specifications.
Latest Update: Gland Pharma IPO subscribed -x times, QIB -x, HNI -x and RII 0.0x times on day 1.
Gland Pharma IPO Subscription Numbers(Day 1 - Till 5:30)
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 0.00x | 0.00x | -x |
| HNI | 0.00x | 0.00x | -x |
| RII | 0.00x | 0.00x | -x |
| EMP | 0.00x | 0.00x | -x |
| OTH | 0.00x | 0.00x | -x |
| Total | 0.00x | 0.00x | -x |
Gland Pharma IPO Dates & Price Band:
| IPO Open: | 09 November 2020. Monday |
|---|---|
| IPO Close: | 11 November 2020, Wednesday |
| Offer Size: | Fresh issue: Rs 1,250 crore; OFS: Rs 5194.6 crore to Rs 5229.5 crore |
| Face Value: | ₹ 1 Per Equity Share |
| Price Band: | ₹ 1490-1500 Per Share |
| Listing on: | NSE & BSE |
| Retail Portion: | 35 % |
| Equity: | 3.48 Crore Shares |
| Type of Issue | Fresh issue of equity shares aggregating to Rs. 1,250 crore and offer for sale of up to 3.48 crore equity shares |
| Lot Size: | Minimum 10 Shares & Maximum 130 Shares |
| Minimum Amount: | ₹15,000 |
| Maximum Amount: | ₹1,95,000 |
Equitas Small Finance Bank IPO Allotment & Listing:
| Basis of Allotment: | 17 November 2020 |
| Refunds: | 18 November 2020 |
| Credit to Demat Account: | 19 November 2020 |
| Listing Date: | 20 November 2020 |
When Gland Pharma IPO Subscription will start?
The IPO subscription starts on 09 November 2020 for QIB, NII, and Retail Investors.
How much Gland Pharma IPO subscribed?
The subscription is not started yet. We will update as soon as we will get the numbers.
What is Gland Pharma IPO retail subscription status?
The retail subscription is not started yet.
How to subscribe Gland Pharma IPO?
You can go with ASBA and Non ASBA option for subscription. Go to your bank account and apply IPO online via ASBA or download form online or get the physical form and submit the filled form to your broker or bank.
How do i check live Gland Pharma IPO Subscription Numbers?
One can visit our portal for live subscription numbers which we are updating hourly basis or check the numbers on NSE and BSE website.
